The Max Cure
The mission of The Max Cure Foundation, Inc., is to fund research for the development of pediatric cancer drugs, including funding to discover less toxic treatments for children with cancer, and as its research mission, to fund an Immune Cell Therapy Lab at Memorial Sloan-Kettering Cancer Center, to financially assist low income and military families battling cancer in their children, and through advocacy, to pursue legislative and regulatory changes that seek to benefit children with cancer and at the same time, raise awareness to the needs of those fighting pediatric cancer.
MCF believes in funding innovative and novel childhood cancer research in an effort to find cures for the various forms of childhood cancer and to create less-toxic and more effective treatments for children and young adults diagnosed with cancer. More than $1.3 million to date has been donated, primarily to fund The Immune Cell Therapy Lab at Memorial Sloan Kettering.
Roar Beyond Barriers
This program provides financial support to low-income and military families who have a child battling cancer intended to help ease some of the burdens on the family while dealing with the child’s diagnosis. Since the creation of the program in 2011, Max Cure has raised over $425,000 and has assisted more than 100 families at 26 hospitals in 17 states where children are in active treatment for their cancers.
The Max Cure Foundation’s leadership team, including our Vice-Chairman, Richard Plotkin and Executive Director, Jonathan Agin, is at the forefront of the childhood cancer advocacy community by relentlessly pursuing legislative and regulatory changes seeking to benefit children with cancer and at the same time, raise awareness to the needs of those fighting pediatric cancers.
To view this organizations website, click here.